We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
On an almost party-line vote of 230-192, the Democrats’ drug pricing bill H.R. 3 made its way out of the House on Thursday with an amendment requiring drugmakers to disclose drug prices in their direct-to-consumer advertising. Read More
The Senate confirmed Stephen Hahn yesterday in a 72-18 vote as the 24th FDA commissioner, taking over for acting FDA Commissioner Brett Giroir. Read More
The FDA served Alkermes with a warning letter for serious violations in the promotion of its opioid addiction treatment Vivitrol (naltrexone for extended-release injectable suspension). Read More
Two dozen states are urging Purdue Pharma to consider specific actions to protect OxyContin patients, including discontinuing the 80 mg OxyContin dose. Read More